Virtu KCG Holdings’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$110K Buy
11,314
+3,588
+46% +$34.9K ﹤0.01% 2375
2017
Q1
$187K Buy
7,726
+4,302
+126% +$104K 0.01% 2453
2016
Q4
$110K Buy
+3,424
New +$110K ﹤0.01% 2859
2016
Q3
Sell
-9,142
Closed -$388K 3716
2016
Q2
$388K Buy
9,142
+5,418
+145% +$230K 0.01% 1600
2016
Q1
$245K Buy
+3,724
New +$245K 0.01% 1882
2015
Q3
Sell
-2,851
Closed -$277K 3556
2015
Q2
$277K Buy
+2,851
New +$277K 0.01% 1756
2015
Q1
Sell
-1,786
Closed -$159K 3408
2014
Q4
$159K Buy
+1,786
New +$159K ﹤0.01% 2149
2014
Q2
Sell
-1,983
Closed -$79K 3082
2014
Q1
$79K Buy
+1,983
New +$79K ﹤0.01% 2075
2013
Q4
Sell
-2,337
Closed -$70K 3177
2013
Q3
$70K Buy
+2,337
New +$70K ﹤0.01% 2352